Form 4: Mannkind Executive Reports Stock Transaction
Insider Transaction (Form 4)
Dominic Marasco, Pres, Endocrine Business Unit of Mannkind Corp, reported a transaction in 3,623 shares of common stock on July 15, 2026.
Summary
- Tax/exercise-price withholding: disposed of 3,623 Common Stock, $0.01 Par Value at $4.09 ($14,818) on July 15, 2026; holds 343,398 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Dominic Marasco — Officer (Pres, Endocrine Business Unit)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-15 | Tax/exercise-price withholding | Common Stock, $0.01 Par Value | 3,623 | $4 | $14.8K | 343,398 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-15 | Tax/exercise-price withholding (3,623 shares) |
Keywords
insider transaction, Form 4, MNKD, MANNKIND CORP, neutral, Dominic Marasco
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.